• 1 November 1973
    • journal article
    • Vol. 15  (3) , 321-30
Abstract
Highly purified blood lymphocytes from treated and untreated patients with plasmacell myeloma were tested for the presence of *EAC lymphocytes carrying the C3 receptor surface marker using a rosette-technique and for thymus-derived (T) lymphocytes as judged by spontaneous rosette formation with sheep red blood cells. The treated patients were tested 5 weeks after a standardized 4-day treatment with melphalan and prednisolone.